Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.

(MedPage Today) -- As an investigational diabetes drug implant that promises better adherence faces FDA review for a third time, safety concerns ranging from adverse heart and kidney events are expected to be points of contention at an advisory...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news